Alliancebernstein L.P. Celcuity Inc. Transaction History
Alliancebernstein L.P.
- $290 Billion
- Q2 2025
A detailed history of Alliancebernstein L.P. transactions in Celcuity Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 28,270 shares of CELC stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,270
Previous 23,680
19.38%
Holding current value
$2.18 Million
Previous $239,000
57.74%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CELC
# of Institutions
111Shares Held
31.7MCall Options Held
40.2KPut Options Held
21.5K-
Baker Bros. Advisors LP New York, NY5.45MShares$420 Million0.74% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$267 Million1.82% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.01MShares$232 Million3.12% of portfolio
-
Nea Management Company, LLC Timonium, MD2.29MShares$177 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$128 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $1.15B
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...